Smith & Nephew SNATS (NYSE:SNN) Hits New 12-Month High - What's Next?

Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Get Free Report) reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $31.84 and last traded at $31.83, with a volume of 760764 shares traded. The stock had previously closed at $30.93.

Analysts Set New Price Targets

Several brokerages have recently commented on SNN. Canaccord Genuity Group upped their price target on Smith & Nephew SNATS from $27.00 to $28.00 and gave the company a "hold" rating in a research note on Thursday, May 1st. Hsbc Global Res lowered shares of Smith & Nephew SNATS from a "strong-buy" rating to a "hold" rating in a report on Friday, April 25th. Finally, HSBC downgraded shares of Smith & Nephew SNATS from a "buy" rating to a "hold" rating in a report on Friday, April 25th. Six investment analysts have rated the stock with a hold rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $28.00.

Smith & Nephew SNATS Price Performance

The company has a market capitalization of $13.87 billion, a PE ratio of 14.66, a P/E/G ratio of 0.97 and a beta of 0.69. The company has a current ratio of 2.89, a quick ratio of 1.33 and a debt-to-equity ratio of 0.62. The stock has a fifty day simple moving average of $29.70 and a 200-day simple moving average of $27.82.

Institutional Investors Weigh In On Smith & Nephew SNATS

Institutional investors and hedge funds have recently bought and sold shares of the stock. Hexagon Capital Partners LLC raised its position in Smith & Nephew SNATS by 63.3% in the first quarter. Hexagon Capital Partners LLC now owns 1,047 shares of the medical equipment provider's stock worth $30,000 after acquiring an additional 406 shares in the last quarter. National Bank of Canada FI boosted its holdings in Smith & Nephew SNATS by 36.5% during the fourth quarter. National Bank of Canada FI now owns 1,667 shares of the medical equipment provider's stock worth $41,000 after buying an additional 446 shares in the last quarter. Ashton Thomas Securities LLC grew its position in Smith & Nephew SNATS by 0.9% during the second quarter. Ashton Thomas Securities LLC now owns 55,911 shares of the medical equipment provider's stock worth $1,713,000 after buying an additional 509 shares during the period. Geneos Wealth Management Inc. increased its holdings in Smith & Nephew SNATS by 15.0% in the first quarter. Geneos Wealth Management Inc. now owns 4,149 shares of the medical equipment provider's stock valued at $118,000 after buying an additional 541 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its position in shares of Smith & Nephew SNATS by 4.8% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 12,462 shares of the medical equipment provider's stock valued at $381,000 after acquiring an additional 570 shares during the period. 25.64% of the stock is owned by hedge funds and other institutional investors.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.